MARKET

SEPN

SEPN

Septerna, Inc.
NASDAQ
48.19
+0.43
+0.90%
After Hours: 48.19 0 0.00% 19:34 08/12 EDT
OPEN
47.93
PREV CLOSE
47.76
HIGH
51.10
LOW
47.40
VOLUME
1.26M
TURNOVER
--
52 WEEK HIGH
51.10
52 WEEK LOW
10.62
MARKET CAP
2.25B
P/E (TTM)
-88.5683
1D
5D
1M
3M
1Y
5Y
1D
Septerna Reaches Analyst Target Price
NASDAQ · 14h ago
Septerna Is Maintained at Overweight by Wells Fargo
Dow Jones · 15h ago
Septerna Price Target Raised to $50.00/Share From $48.00 by Wells Fargo
Dow Jones · 15h ago
Wells Fargo Maintains Overweight on Septerna, Raises Price Target to $50
Benzinga · 15h ago
Septerna, Inc. (SEPN) Receives a Buy from Wells Fargo
TipRanks · 17h ago
Analysts Conflicted on These NA Names: Septerna, Inc. (SEPN) and Douglas AG (OtherDOUDF)
TipRanks · 17h ago
Septerna Price Target Raised to $60.00/Share From $40.00 by HC Wainwright & Co.
Dow Jones · 17h ago
Septerna Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 17h ago
More
About SEPN
Septerna, Inc. is a clinical-stage biotechnology company. The Company is developing G protein-coupled receptor (GPCR) oral small-molecule drug discovery powered by its proprietary Native Complex Platform. Its pipeline of product candidates is focused on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Its industrial-scale Native Complex Platform is designed to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to achieve desired therapeutic effects. It is advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with unmet needs. It is focused on therapeutic areas, such as neurology, women’s health, cardiovascular, and respiratory disease.

Webull offers Septerna, Inc. stock information, including NASDAQ: SEPN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SEPN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SEPN stock methods without spending real money on the virtual paper trading platform.